Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 3
1982 6
1983 4
1984 2
1985 4
1986 8
1987 4
1988 1
1989 2
1990 3
1991 7
1992 5
1993 4
1994 8
1995 3
1996 10
1997 14
1998 12
1999 28
2000 61
2001 50
2002 61
2003 54
2004 51
2005 61
2006 65
2007 67
2008 68
2009 70
2010 86
2011 88
2012 86
2013 97
2014 88
2015 131
2016 177
2017 250
2018 264
2019 333
2020 371
2021 428
2022 415
2023 120
Text availability
Article attribute
Article type
Publication date

Search Results

3,179 results
Results by year
Filters applied: . Clear all
Page 1
Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI).
Maegele M. Maegele M. Transfus Med Rev. 2021 Oct;35(4):87-90. doi: 10.1016/j.tmrv.2021.08.003. Epub 2021 Sep 4. Transfus Med Rev. 2021. PMID: 34598876 Review.
The results from the CRASH-3 trial have promoted the implementation of the antifibrinolytic tranexamic acid (TXA) into prehospital Emergency Medical Services (EMS) protocols. ..."The Prehospital TXA for TBI"-trial. Simultaneously, the results from a retrospective an …
The results from the CRASH-3 trial have promoted the implementation of the antifibrinolytic tranexamic acid (TXA) into prehospital Em …
Oral Tranexamic Acid for the Treatment of Melasma: A Review.
Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M. Bala HR, et al. Dermatol Surg. 2018 Jun;44(6):814-825. doi: 10.1097/DSS.0000000000001518. Dermatol Surg. 2018. PMID: 29677015 Review.
OBJECTIVE: To provide a comprehensive review of the literature regarding the evidence on the mode of action, safety profile, and efficacy of TXA in the treatment of melasma. MATERIALS AND METHODS: The literature was searched for publications on TXA in the treatment …
OBJECTIVE: To provide a comprehensive review of the literature regarding the evidence on the mode of action, safety profile, and efficacy of …
Tranexamic acid evidence and controversies: An illustrated review.
Relke N, Chornenki NLJ, Sholzberg M. Relke N, et al. Res Pract Thromb Haemost. 2021 Jul 14;5(5):e12546. doi: 10.1002/rth2.12546. eCollection 2021 Jul. Res Pract Thromb Haemost. 2021. PMID: 34278187 Free PMC article. Review.
Tranexamic acid (TXA) is an antifibrinolytic agent commonly used for the treatment or prevention of bleeding. ...Despite decades of use and a robust body of evidence, hesitancy using TXA persists in many clinical settings. This illustrated review describes the histo …
Tranexamic acid (TXA) is an antifibrinolytic agent commonly used for the treatment or prevention of bleeding. ...Despite decades of u …
Toxicity of tranexamic acid (TXA) to intra-articular tissue in orthopaedic surgery: a scoping review.
Bolam SM, O'Regan-Brown A, Paul Monk A, Musson DS, Cornish J, Munro JT. Bolam SM, et al. Knee Surg Sports Traumatol Arthrosc. 2021 Jun;29(6):1862-1871. doi: 10.1007/s00167-020-06219-7. Epub 2020 Aug 29. Knee Surg Sports Traumatol Arthrosc. 2021. PMID: 32860523 Review.
Our aim was to review the literature for evidence of toxic effects from TXA exposure to intra-articular tissue. METHODS: A scoping review methodology was used to search for studies assessing the toxic effects of TXA exposure to intra-articular tissues. ...There is a …
Our aim was to review the literature for evidence of toxic effects from TXA exposure to intra-articular tissue. METHODS: A scoping re …
Efficacy of tranexamic acid (TXA) for post-tonsillectomy hemorrhage.
Spencer R, Newby M, Hickman W, Williams N, Kellermeyer B. Spencer R, et al. Am J Otolaryngol. 2022 Sep-Oct;43(5):103582. doi: 10.1016/j.amjoto.2022.103582. Epub 2022 Aug 6. Am J Otolaryngol. 2022. PMID: 35988367
Collected data of PTH patients included age, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, length of stay (LOS), the requirement of a blood transfusion, day of PTH, TXA usage and route, complications from TXA administration, and …
Collected data of PTH patients included age, body mass index (BMI), American Society of Anesthesiologists (ASA) classification, length of st …
The Use of Tranexamic Acid (TXA) for the Management of Hemorrhage in Trauma Patients in the Prehospital Environment: Literature Review and Descriptive Analysis of Principal Themes.
Stansfield R, Morris D, Jesulola E. Stansfield R, et al. Shock. 2020 Mar;53(3):277-283. doi: 10.1097/SHK.0000000000001389. Shock. 2020. PMID: 32044848 Review.
Tranexamic acid (TXA) is an antifibrinolytic agent used to prevent traumatic exsanguination. ...These articles were thoroughly analyzed and the following themes were identified: "dose of TXA administration," "route of TXA administration," "optimal window of …
Tranexamic acid (TXA) is an antifibrinolytic agent used to prevent traumatic exsanguination. ...These articles were thoroughly analyz …
TXA (Tranexamic Acid) Risk Evaluation in Combat Casualties (TRECC).
Adair KE, Patrick JD, Kliber EJ, Peterson MN, Holland SR. Adair KE, et al. Trauma Surg Acute Care Open. 2020 Jan 8;5(1):e000353. doi: 10.1136/tsaco-2019-000353. eCollection 2020. Trauma Surg Acute Care Open. 2020. PMID: 32072015 Free PMC article.
RESULTS: Subjects (n=620) met inclusion criteria with 27% (n=169) having a documented VTE. A total of 30% that received TXA had a documented VTE, 26% that did not receive TXA had a documented VTE and 43% (n=264, n=620) of the sample did not have TXA documente …
RESULTS: Subjects (n=620) met inclusion criteria with 27% (n=169) having a documented VTE. A total of 30% that received TXA had a doc …
Tranexamic acid: Beyond antifibrinolysis.
Prudovsky I, Kacer D, Zucco VV, Palmeri M, Falank C, Kramer R, Carter D, Rappold J. Prudovsky I, et al. Transfusion. 2022 Aug;62 Suppl 1:S301-S312. doi: 10.1111/trf.16976. Epub 2022 Jul 14. Transfusion. 2022. PMID: 35834488 Review.
TXA binds plasminogen and prevents its maturation to the fibrinolytic enzyme plasmin. ...Besides preventing fibrinolysis and blood loss, TXA has been reported to suppress posttraumatic inflammation and edema. ...
TXA binds plasminogen and prevents its maturation to the fibrinolytic enzyme plasmin. ...Besides preventing fibrinolysis and blood lo …
Tranexamic Acid for Melasma Treatment: A Split-Face Study.
Ebrahim HM, Said Abdelshafy A, Khattab F, Gharib K. Ebrahim HM, et al. Dermatol Surg. 2020 Nov;46(11):e102-e107. doi: 10.1097/DSS.0000000000002449. Dermatol Surg. 2020. PMID: 32701529 Clinical Trial.
OBJECTIVE: This study was conducted to evaluate the therapeutic effect and safety of TXA by intradermal injection versus TXA with microneedling for melasma treatment. ...No significant adverse effects were observed in both treated sides. CONCLUSION: Intradermal inje …
OBJECTIVE: This study was conducted to evaluate the therapeutic effect and safety of TXA by intradermal injection versus TXA w …
Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review.
Ockerman A, Vanassche T, Garip M, Vandenbriele C, Engelen MM, Martens J, Politis C, Jacobs R, Verhamme P. Ockerman A, et al. Thromb J. 2021 Aug 11;19(1):54. doi: 10.1186/s12959-021-00303-9. Thromb J. 2021. PMID: 34380507 Free PMC article. Review.
TXA reduces mortality in patients suffering from trauma and postpartum hemorrhage. For many of these indications, there is no consensus about the optimal TXA dose. With certain dosages and with certain indications TXA can cause harm, such as an increased risk …
TXA reduces mortality in patients suffering from trauma and postpartum hemorrhage. For many of these indications, there is no consens …
3,179 results